Sanaz Taromi

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Cell Cycle Arrest

Insulin Resistance

Highly Efficient

Top Venues

Molecular cancer research : MCR

Nature communications

Nature immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Marlene Langenbach, Sophie Giesler, Stefan Richtsfeld, Sara Costa-Pereira, Lukas Rindlisbacher, Tobias Wertheimer, Lukas M Braun, Geoffroy Andrieux, Sandra Duquesne, Dietmar Pfeifer, Nadine M Woessner, Hans D Menssen, Sanaz Taromi, Justus Duyster, Melanie Börries, Tilman Brummer, Bruce R Blazar, Susana Minguet, Patrick Turko, Mitchell Paul Levesque, Burkhard Becher, Robert Zeiser
MDM2 inhibition enhances immune checkpoint inhibitor efficacy by increasing IL-15 and MHC class II production. Molecular cancer research : MCR (2023)
Rubí M-H Velasco Cárdenas, Simon M Brandl, Ana Valeria Meléndez, Alexandra Emilia Schlaak, Annabelle Buschky, Timo Peters, Fabian Beier, Bryan Serrels, Sanaz Taromi, Katrin Raute, Simon Hauri, Matthias Gstaiger, Silke Lassmann, Johannes B Huppa, Melanie Börries, Geoffroy Andrieux, Bertram Bengsch, Wolfgang W A Schamel, Susana Minguet
Harnessing CD3 diversity to optimize CAR T cells. Nature immunology (2023)
Nadia El Khawanky, Amy Hughes, Wenbo Yu, Renier Myburgh, Tony Matschulla, Sanaz Taromi, Konrad Aumann, Jade Clarson, Janaki Manoja Vinnakota, Khalid Shoumariyeh, Christoph Cornelius Miething, Angel F Lopez, Michael P Brown, Justus Duyster, Lutz Hein, Markus Gabriel Manz, Timothy P Hughes, Deborah L White, Agnes S M Yong, Robert Zeiser
Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia. Nature communications 12 (1) (2021)